Targeted Genetics chronicles

Selected events tracked against Targeted Genetics' weekly stock price since the company's IPO in 1994. Y-axis = log scale A. 5/20/94 - Raises $12M in IPOB. 7/14/95 - Raises $11.7M in private placement of units C. 11/95 - Starts Phase I testing of tgAAVCF for cystic fibrosis (CF)

D. 6/96 - Acquires RGene Therapeutics for $18M in stock (pre-split price) and raises $14M in follow-onE. 10/96 - Starts Phase I testing of tgDCC-E1A for head and neck cancerF. 4/20/98 - Raises $13.1M in PIPE...